News Ticker

[ May 26, 2022 ] Senior Marketing Manager – Biotech mRNA -Life Sciences – Maravai LifeSciences – San Diego, CA San Diego Biotech Jobs
[ May 26, 2022 ] Staff Scientist – Maravai LifeSciences – San Diego, CA San Diego Biotech Jobs
[ May 26, 2022 ] MEI Pharma and Kyowa Kirin Announce Acceptance of Abstract for Presentation at the American Society of Clinical Oncology Annual Meeting 2022 News
[ May 26, 2022 ] Gracell Biotechnologies to Present Updated Clinical Data on BCMA/CD19 Dual-Targeting CAR-T GC012F for Relapsed/Refractory Multiple Myeloma at 2022 ASCO Annual Meeting News
[ May 26, 2022 ] Investigational Adagrasib Delivers Positive Results in Registration-Enabling Study of Patients with KRASG12C-Mutated Advanced Non-Small Cell Lung Cancer News

Carlsbad’s Ionis gets $25M upfront for licensing hepatitis B drugs to GSK

August 27, 2019 sandiegobiotech News Comments Off

Carlsbad's Ionis gets $25M upfront for licensing hepatitis B drugs to GSK

00:00 /

Hundreds of millions more possible to Ionis if drugs reach milestones

Copyright © 2022 Biotech Networks, LLC